REQUEST A DEMO
Total
USD $0.00
Search more companies

Reprogenesis A.S. (Czech Republic)

Main Activities: Ambulatory Health Care Services | Offices of Physicians
Full name: Reprogenesis A.S. Profile Updated: August 25, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Reprogenesis A.S. is an enterprise in Czech Republic, with the main office in Brno. It operates in the Ambulatory Health Care Services sector. The company was established on November 12, 2010. The total number of employees is currently 25 - 49 (2026). The company’s latest financial report indicates a net sales revenue increase of 13.89% in 2024. During that time, Reprogenesis A.S.’s total assets grew by 7.04%. In 2024, Reprogenesis A.S.’s net profit margin increased by 4.75%.

Headquarters
Hlinky 60/144
Brno; Jihomoravsky; Postal Code: 60300

Contact Details: Purchase the Reprogenesis A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Reprogenesis A.S. report to view the information.
Registered Capital:
Purchase the Reprogenesis A.S. report to view the information.
Financial Auditors:
Purchase the Reprogenesis A.S. report to view the information.
Incorporation Date:
November 12, 2010
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Reprogenesis A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
13.89%
Total Operating Revenue
-21.74%
Operating Profit
90.18%
EBITDA
78.56%
Net Profit/Loss for the Period
63.58%
Total Assets
7.04%
Total Equity
211.76%
Operating Profit Margin
9.12%
Net Profit Margin
4.75%
Return on Equity (ROE)
-39.61%
Debt / Equity
-216.4%
Quick Ratio
1.2%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?